Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Tiantan Biological Products (SHSE:600161) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Beijing Tiantan Biological Products PS Ratio Related Terms
Beijing Tiantan Biological Products PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tiantan Biological Products PS Ratio Chart
SHSE:600161 vs VRTX, REGN, ALNY: PS Ratio Comparison
For the Biotechnology subindustry, Beijing Tiantan Biological Products's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Tiantan Biological Products PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Tiantan Biological Products's PS Ratio distribution charts can be found below:
* The bar in red indicates where Beijing Tiantan Biological Products's PS Ratio falls into.
Beijing Tiantan Biological Products PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Beijing Tiantan Biological Products's Share Price of today is ¥12.84. Beijing Tiantan Biological Products's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Beijing Tiantan Biological Products (SHSE:600161) has a PS Ratio of 4.25 as of Jul. 20, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Beijing Tiantan Biological Products and its competitors. This is 52% below median its historical median of 8.77. Over the past decade, Beijing Tiantan Biological Products' PS Ratio has ranged from 3.78 to 18.60. According to the industry distribution chart, Beijing Tiantan Biological Products ranks #276 out of 930 companies in the Biotechnology industry, placing it in the top 29.7%.
Is Beijing Tiantan Biological Products' PS Ratio too high?
Beijing Tiantan Biological Products' current PS Ratio of 4.25 is 52% below median its 10-year median of 8.77. Over the past 10 years, this metric has ranged from a low of 3.78 to a high of 18.60. The Biotechnology industry median PS Ratio is 9.35. Beijing Tiantan Biological Products' value of 4.25 is 54.5% below this industry median. Based on the distribution chart, Beijing Tiantan Biological Products ranks #276 out of 930 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Beijing Tiantan Biological Products has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tiantan Biological Products' PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Tiantan Biological Products ranks #276 out of 930 companies for PS Ratio. This puts Beijing Tiantan Biological Products in the upper half of its industry. The industry median PS Ratio is 9.35. Beijing Tiantan Biological Products' value of 4.25 is 54.5% below this benchmark. Historically, Beijing Tiantan Biological Products' own PS Ratio has ranged from 3.78 to 18.60 over the past decade. While the company's 10-year median is 8.77 vs. the industry median of 9.35, Beijing Tiantan Biological Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.35, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Tiantan Biological Products's current PS Ratio of 4.25 is 54.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Beijing Tiantan Biological Products and its competitors. For the Biotechnology industry, the median PS Ratio is 9.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Tiantan Biological Products's current PS Ratio is 4.25, which is 52% below median its own 10-year median of 8.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tiantan Biological Products stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products (SHSE:600161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥23.05, compared to a current price of ¥12.84 — trading 44.3% below its estimated fair value. The current PS Ratio is 4.25, which is 52% below median its 10-year median of 8.77 and 54.5% below the Biotechnology industry median of 9.35. Beijing Tiantan Biological Products' overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Beijing Tiantan Biological Products (SHSE:600161), the current PS Ratio is 4.25 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Tiantan Biological Products (SHSE:600161) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products stock appears to be undervalued.
The current stock price of ¥12.84 is trading 44.3% below its estimated GF Value™ of ¥23.05.
GuruFocus considers Beijing Tiantan Biological Products to be Significantly Undervalued.
Key valuation signals for SHSE:600161:
PS Ratio: 4.25 (52% below median its 10-year median of 8.77)
GF Value™: ¥23.05 vs. price of ¥12.84 (44.3% below fair value)
Industry Position: 54.5% below the Biotechnology median (#276 of 930)
No single metric tells the full story. See the SHSE:600161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Tiantan Biological Products Business Description
Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business. The company's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human hepatitis B immunoglobulin, human immunoglobulin, human rabies immunoglobulin, human histamine immunoglobulin, and others.
68GF Score
Get the complete analysis for SHSE:600161
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600161 has been successfully added to your 
